PBX1 and cancer: The “Oncomine” database shows that abnormal PBX1 overexpression exists in numerous cancer categories, including renal clear cell carcinomas (ccRCCs), accounting for 70% of renal tumors (Zhang et al., 2016; Hsieh et al., 2017; Wei et al., 2018).